v3.26.1
Condensed Statement of Changes in Shareholders' Equity - USD ($)
Total
Ordinary Shares [Member]
Stock Subscription Receivable from Shareholders [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Beginning balance at Jul. 23, 2024 $ 0 $ 0 $ 0 $ 0 $ 0
Beginning balance, shares at Jul. 23, 2024   0      
Ordinary shares issued to Sponsor   $ 383 (25,000) 24,617  
Ordinary shares issued to Sponsor, shares   3,833,333      
Ordinary shares issued to underwriter 1,538,400 $ 27   1,538,373  
Ordinary shares issued to underwriter, shares   266,667      
Sale of Private Placement Units $ 4,000,000 $ 400   3,999,960  
Sale of Private Placement Units, shares 400,000 400,000      
Fair value of rights included in Public Units $ 1,379,000     1,379,000  
Allocated value of transaction costs to Public Rights 137,841     137,841  
Allocated value of transaction costs to redeemable shares (137,841)     (137,841)  
Remeasurement | Accretion of carrying value to redemption value (5,918,545)     (5,918,545)  
Collection of stock subscription receivable from shareholder 25,000   25,000    
Net Income (Loss) (39,474)       (39,474)
Ending Balance at Dec. 31, 2024 846,540 $ 450 0 885,564 (39,474)
Ending balance, shares at Dec. 31, 2024   4,500,000      
Sale of Private Placement Units $ 375,000 $ 4   374,996  
Sale of Private Placement Units, shares 37,500 37,500      
Fair value of rights included in Public Units $ 206,850     206,850  
Fair value of over-allotment exercised 148,416     148,416  
Allocated value of transaction costs to Public Rights (3,878)     (3,878)  
Allocated value of transaction costs to redeemable shares 3,878     3,878  
Remeasurement | Accretion of carrying value to redemption value (5,397,684)     (1,611,948) (3,785,736)
Net Income (Loss) 4,035,451       4,035,451
Ending Balance at Dec. 31, 2025 $ 210,695 $ 454 $ 0 $ 0 $ 210,241
Ending balance, shares at Dec. 31, 2025   4,537,500